A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether adrenaline might be a useful addition to a protocol for the management of cardiac arrests for patients shortly after cardiac surgery. Altogether 889 papers were found using the reported search, of which 16 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. The quality and level of evidence was assessed using the International Liaison Committee on Resuscitation guideline recommendations. We conclude that the European Resuscitation Council and the American Heart Association both recommend 1 mg of adrenaline as soon as pulseless electrical activity or asystole is identified or after the second failed shock if the rhythm is VFypulseless VT. However, they acknowledge that the evidence behind this recommendation is lacking and based entirely on animal studies which have as yet not been successfully replicated in human studies to show a benefit of survival to hospital discharge. They acknowledge that the current evidence is insufficient to support or refute the use of adrenaline in arrests and the International Liaison Committee on Resuscitation grade the recommendation to give adrenaline in cardiac arrests as 'indeterminate'. Thus, in the particular situation of a patient who arrests shortly after cardiac surgery where the chance of restoring sinus rhythm either by defibrillation or by an emergency re-sternotomy is high, and where adrenaline could in this situation be highly dangerous once sinus rhythm is restored, we recommend that 1 mg of adrenaline forms no part of the resuscitation protocol for patients who arrest after cardiac surgery.
Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS w1x. The quality of each study was assessed using the International Liaison Committee on Resuscitation 2005 protocol w2x.
Three-part question
In wpatients who have arrested shortly after cardiac surgeryx does wthe routine administration of 1 mg of adrenalinex improve wsurvivalx?
Clinical scenario
A 72-year-old patient suffers a cardiac arrest 1 h after triple coronary artery bypass graft. The rhythm is pulseless electrical activity (PEA). The nursing staff commence cardiac massage and follow the European Resuscitation Council guideline which is to give 1 mg of adrenaline immediately for pulseless electrical activity (PEA) or asystole. The supported by animal studies: many in the past and 3 in the last Hypothesis: Epinephrine 5 years. (level of evidence 6). Systematic review of (at either standard doses It does provide adverse consequences as well, and subsequent doses do experimental studies or higher doses) is a safe not appear to provide as dramatic an effect in raising coronary (level 6, excellent) and effective adjunct to perfusion pressure (and thus chance of ROSC) as the first dose defibrillation in cardiac However, due to the lack of human placebo-controlled trials, arrests due to ventricular epinephrine is Class Indeterminate. For PEA and asystole, the use of fibrillation (asystole also epinephrine is also Class Indeterminate considered)
Epinephrine, 1 mg IV, given every 3-5 min, is generally accepted as useful in cardiac arrest from all rhythms although no human trials have compared epinephrine to placebo Cairns et al., (1998) 
Search outcome
Three hundred and twenty-eight papers were found in MEDLINE, 499 in EMBASE and 62 in the Cochrane collection using the reported search. From these, 16 papers were identified that provided the best evidence to answer the question. These are presented in Table 1 .
Results
The 2005 European Resuscitation Council Guidelines (ERC w3x) and the American Heart Association guidelines w4x state that for patients suffering a cardiac arrest with PEA or asystole, 1 mg of adrenaline should be given as soon as intravascular access is achieved and for every 3-5 min or every other loop of the algorithm. For VFyVT, adrenaline should be given after the second failed shock. However, the ERC state that 'despite the widespread use of adrenaline during resuscitation, and several studies involving vasopressin, there is no placebo controlled study that shows that the routine use of any vasopressor at any stage during human cardiac arrest increases survival to hospital discharge. Current evidence is insufficient to support or refute the routine use of any particular drug or sequence of drugs. Despite the lack of human data, the use of adrenaline is still recommended, based largely on animal data.' The evidence that they base this recommendation on are the worksheets produced by Long and Paradis w5x and Wenzel w6x. Long concludes that adrenaline use is supported by recent animal studies but that no human studies compare it to placebo. Also, they note that it produces adverse consequences and also subsequent doses are less effective. They give the level of evidence for adrenaline for VF or PEAyasystole as 'indeterminate' which is defined as 'minimal evidence available, results inconsistent and contradictory and results not compelling'
Cairns and Niemann w7x studied 14 dogs who had VF for 7.5 min prior to resuscitation attempts. Three dogs survived and adrenaline increased their coronary perfusion pressure (CPP) by 21"11 mmHg. However, in the remainder, adrenaline only increased the CPP by 3"2 mmHg. Also subsequent doses had minimal effect on CPP.
Klouche et al. w8x studied 20 rats using differing resuscitative drugs after VF. They found that adrenaline impaired post-resuscitation myocardial function more than vasopressin and a selective alpha-agonist, and this function was similar to saline-placebo controls. However, survival was superior with adrenaline than with controls.
Lindberg et al. w9x in 18 pigs who had a sternotomy and chest closure, and then VF, showed that while either adrenaline or noradrenaline increased CPP during the arrest up to 45 mmHg compared to only 7 mmHg for controls, it significantly impaired cardiac output and oxygen delivery after successful resuscitation.
Chen et al. w10x, in 47 rabbits arrested after ET-tube clamping, found that adrenaline increased CPP from 4 to 38 mmHg whereas vasopressin failed to do this. Half the rabbits given adrenaline survived compared to 10% of the vasopressin group.
Ristagno et al. w11x showed significantly worse cerebral blood flows and oxygenation with adrenaline compared to vasopressin in 10 pigs after cardiac arrest.
Vandycke and Martens w12x performed a meta-analysis of five RCTs of high-dose adrenaline vs. standard dose adrenaline. They found a superior odds of return of spontaneous circulation but no difference to hospital admission and a poorer outcome to hospital discharge with higher doses of adrenaline. Biondi-Zoccai et al. w13x performed a metaanalysis of vasopressin vs. adrenaline, finding only two human studies but demonstrating superiority of vasopressin across 33 animal studies. Zhong and Dorian w14x performed a review of adrenaline and vasopressin in cardiac arrest stating that adrenaline had many adverse effects postresuscitation including myocardial dysfunction, worsening arrhythmias and increased myocardial oxygen demand and that human studies in this area were urgently needed.
Holmberg et al. w15x in a survey of 11,000 patients in patient-care who had arrested out-of-hospital looked at risk factors for adverse survival. They found that adrenaline was a predictor of adverse outcome for asystolic and VF arrests. Behringer et al. w16x reported that in 178 patients who survived an out-of-hospital arrest that adrenaline cumulative dose was much higher in those patients with a poor neurological outcome. The best human study in this area compared vasopressin with adrenaline but had no placebo group. Wenzel et al. w17x randomized over 1000 patients who arrested out-of-hospital to vasopressin or adrenaline. There was no difference in VF arrests but asystole and combined vasopressin and adrenaline showed better survival to hospital admission.
Pytte et al. w18x was struck by the fact that the benefit of adrenaline seen in experimental studies had not translated into clinical studies and hypothesised that this may be due to the difference between clinical CPR and the CPR obtained in a laboratory by hydraulic-compression devices. They compared these types of CPR and found that while labCPR produced significant haemodynamic effects with adrenaline, no haemodynamic increases were seen with clinicalCPR. Also the peak adrenaline level took 2.5 min to achieve in the clinicalCPR group after a single administration.
Clinical bottom line
The European Resuscitation Council and the American Heart Association both recommend 1 mg of adrenaline as soon as pulseless electrical activity or asystole is identified or after the second failed shock if the rhythm is VFy pulseless VT. However, they acknowledge that the evidence behind this recommendation is lacking and based entirely on animal studies which have as yet not been successfully replicated in human studies and thus the evidence for this recommendation is 'indeterminate'. Thus, in the particular situation of a patient who arrests shortly after cardiac surgery where the chance of restoring sinus rhythm either by defibrillation or by an emergency re-sternotomy is high, and where adrenaline could in this situation be highly dangerous once sinus rhythm is restored, we recommend that 1 mg of adrenaline forms no part of the resuscitation protocol for patients after cardiac surgery. The intravenous administration of 1 mg of adrenaline should not be recommended in cardiac arrest after cardiac surgery. Emphasis should instead be given to external cardiac compression, immediate defibrillation, rapid correction of reversible causes and early emergency re-sternotomy if appropriate. The European Resuscitation Council (ERC) should consider changing their guidelines for the resuscitation of patients who suffer cardiac arrest following cardiac surgery w3x. Most of the time emergency re-thoracotomy is the effective method to solve the problem causing a circulatory arrest after cardiac surgery. The authors state correctly that there is no evidence for injecting adrenaline to treat the loss of circulation w1x. If the cause of the cardiac arrest is not resolved by the re-thoracotomy, the surgeon can very easily inject adrenaline directly into the left ventricle of the heart. Moreover, this method in combination with internal cardiac massage guarantees that the adrenaline reaches the coronary circulation in contrast to an intravenous injection of adrenaline in the circumstances of a circulatory arrest. I don't recommend adrenaline for post CABG arrest w1x. I think it is better to come back to the operating room promptly, if normal condition doesn't return after primary works. Placement of CPB, examination of grafts and redoing CABG (on pump, beating) is the best option. If grafts are apparently normal, then redo CABG from the most important target vessels (on pump, beating). After each graft we try to be off from CPB. If everything is OK, the chest is closed, if not, other important grafts will begin. I think immediate re-sternotomy for other post cardiac surgery arrest is the procedure of choice if external massage is ineffective. Regarding the administration of (intravenous) epinephrine for the earlypost-operative cardiac surgical patient after the fact of the occurrence of complete circulatory arrest w1x I am an agnostic.
That said, I have found i.v. bolus epinephrine can occasionally avert the aforementioned scenario for the patient in a rapid downward 'death spiral'. In my experience this near-arrest physiology results from abrupt vasodilatory decompensation, for example when suddenly coughing (i.e. valsalva condition) as sedation wears off. And here is the point I would like to emphasize. The crucial form of epinephrine here is the 1 mg/10 cc (usually as a 'Bristoject' male leur lock adapter). Push and flush 50 to 100 mg (0.5 to 1 cc) and the patient in jeopardy pulls out of the dive just skimming the treetops. Push the 'arrest dose' of 1 mg/1 cc and as amply noted by others on this concept, the vasodilatory crisis morphs into a hemorrhagic disaster of busted suture line(s) or cannulation site(s).
In summary: Ban the 1 mg/1 cc epinephrine syringes. Keep the 1 mg/10 cc dosage form handy. Your article w1x is very interesting as it fills a gap of knowledge about the correct administration of adrenaline in postoperative cardiac patients suffering from cardiac arrest. According to the European Resuscitation Council w2x and the American Heart Association w3x, a bolus of 1 mg of adrenaline is indicated as soon as pulseless electrical activity or asystole is identified or after the second failed shock, if the rhythm is VF or pulseless VT. The target of this administration is double: firstly to induce ventricular fibrillation or tachycardia (for a successful subsequent defibrillation), and secondly to increase the systemic vascular resistance and restore through this way, a better tissue perfusion. The most important of the targets mentioned above is the first, because the main demand in an asystolic patient in arrest is to retrieve any cardiac activity, even a ventricular fibrillation. However, the second target (to increase the systemic vascular resistance) is achieved much later, either after retrieving a normal rhythm or restoring the circulation by heart massage. In our opinion, adrenaline is indicated ONLY in the patients with no ventricular activity. If ventricular activity is recognized, the so called pulseless electrical activity (ventricular fibrillation or tachycardia), as in the patient in your scenario, the administration of adrenaline does not take place in CPR. Besides, in case of cardiac tamponade, we usually have an empty heart with no myocardial dysfunction, and the rhythm is mostly normal, or later (due to either myocardial hypoperfusion or/and metabolic acidosis) ventricular fibrillation is observed. In contrast, a myocardial dysfunction with dilation is observed in case of a rhythm characterized by junctional bradycardia, or asystolia. Especially in the cardiac surgical patient, the asystolic arrest is not rare. Systemic influences that increase extracellular Kq concentration, such as low PO 2 , metabolic acidosis, renal failure, hypothermia, hemolysis and myocardial trauma, contribute to a partial depolarization of normal or already diseased His-Purkinje system w4x. In this case of arrest, the administration of adrenaline and the abrupt performance of external cardiac massage, may 'brake down' the vicious circle until the reopening of sternotomy for a more effective massage. Obviously, after recovery of VT or VF and an unsuccessful defibrillation, administration of 1 mg adrenaline every 3 to 5 minutes is clearly indicated w2, 3x. While the moderate use of adrenaline during post-cardiac surgery arrest is desirable; as we avoid all its adverse effects on the myocardium (increased myocardial oxygen consumption, sustained arrhythmias, and further dysfunction), as well as on the brain (decreased cerebral flow, worsening of brain ischemia) w5x.
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